Related references
Note: Only part of the references are listed.Discovery of novel 6-hydroxybenzothiazole urea derivatives as dual Dyrk1A/α-synuclein aggregation inhibitors with neuroprotective effects
Yasmeen T. AlNajjar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
DYRK1A inhibitors for disease therapy: Current status and perspectives
Tong Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Novel and Potential Small Molecule Scaffolds as DYRK1A Inhibitors by Integrated Molecular Docking-Based Virtual Screening and Dynamics Simulation Study
Mir Mohammad Shahroz et al.
MOLECULES (2022)
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
Bin Lan et al.
CANCERS (2022)
Small-molecule discovery in the pancreatic beta cell
Bridget K. Wagner
CURRENT OPINION IN CHEMICAL BIOLOGY (2022)
The chromosome 21 kinase DYRK1A: emerging roles in cancer biology and potential as a therapeutic target
Malini Rammohan et al.
ONCOGENE (2022)
Genetic Mapping of APP and Amyloid-? Biology Modulation by Trisomy 21
Paige Mumford et al.
JOURNAL OF NEUROSCIENCE (2022)
DYRK1A Regulates the Bidirectional Axonal Transport of APP in Human-Derived Neurons
Ivan Fernandez Bessone et al.
JOURNAL OF NEUROSCIENCE (2022)
Disrupting the DREAM complex enables proliferation of adult human pancreatic β cells
Peng Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Disease Modeling of Rare Neurological Disorders in Zebrafish
Myeongjoo Son et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection
Jin Wei et al.
CELL (2021)
DYRK1A: a down syndrome-related dual protein kinase with a versatile role in tumorigenesis
Amina Jamal Laham et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Protein phosphatase PPM1B inhibits DYRK1A kinase through dephosphorylation of pS258 and reduces toxic tau aggregation
Ye Hyung Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3
Rahul S. Bhansali et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
The Risks of miRNA Therapeutics: In a Drug Target Perspective
Song Zhang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome
Veronique Brault et al.
PLOS GENETICS (2021)
Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors
Csaba Weber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
A subcellular map of the human kinome
Haitao Zhang et al.
ELIFE (2021)
Interplay Between CMGC Kinases Targeting SR Proteins and Viral Replication: Splicing and Beyond
Florentin Pastor et al.
FRONTIERS IN MICROBIOLOGY (2021)
Alzheimer disease
David S. Knopman et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Global phosphoproteomics reveals DYRK1A regulates CDK1 activity in glioblastoma cells
Ariadna Recasens et al.
CELL DEATH DISCOVERY (2021)
DYRK1a mediates BAFF-induced noncanonical NF-κB activation to promote autoimmunity and B-cell leukemogenesis
Yanchuan Li et al.
BLOOD (2021)
Integrative approach to interpret DYRK1A variants, leading to a frequent neurodevelopmental disorder
Jeremie Courraud et al.
GENETICS IN MEDICINE (2021)
GSK-3β, FYN, and DYRK1A: Master Regulators in Neurodegenerative Pathways
Stefania Demuro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Diabetic Kinome Inhibitors-A New Opportunity for β-Cells Restoration
Barbara Pucelik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview
Mattias F. Lindberg et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Trends in kinase drug discovery: targets, indications and inhibitor design
Misty M. Attwood et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Global kinome profiling reveals DYRK1A as critical activator of the human mitochondrial import machinery
Corvin Walter et al.
NATURE COMMUNICATIONS (2021)
DYRK1A Kinase Inhibitors Promote β-Cell Survival and Insulin Homeostasis
Agata Barzowska et al.
CELLS (2021)
Diagnosis and Treatment of Parkinson Disease A Review
Melissa J. Armstrong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The Dual-Specificity Kinase DYRK1A Modulates the Levels of Cyclin L2 To Control HIV Replication in Macrophages
Javan K. Kisaka et al.
JOURNAL OF VIROLOGY (2020)
A brief history of human disease genetics
Melina Claussnitzer et al.
NATURE (2020)
Two drugs converged in a pancreatic β cell
Marissa A. Scavuzzo et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration
Courtney Ackeifi et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Yonghan He et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Screen identifies DYRK1B network as mediator of transcription repression on damaged chromatin
Chao Dong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Selective DYRK1A Inhibitor for the Treatment of Neurodegenerative Diseases: Alzheimer, Parkinson, Huntington, and Down Syndrome
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2020)
Small Molecule Inhibitors of DYRK1A Identified by Computational and Experimental Approaches
Hye Ree Yoon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
Sarah J. Tabrizi et al.
NATURE REVIEWS NEUROLOGY (2020)
DYRK1A and cognition: A lifelong relationship
Maria L. Arbones et al.
PHARMACOLOGY & THERAPEUTICS (2019)
DYRK1A regulates the recruitment of 53BP1 to the sites of DNA damage in part through interaction with RNF169
Vijay R. Menon et al.
CELL CYCLE (2019)
Heart Disease and Stroke Statistics-2019 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2019)
Metabolomics of Type 1 and Type 2 Diabetes
Borros Arneth et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease
Benoit Melchior et al.
AGING CELL (2019)
Chronic Dyrk1 Inhibition Delays the Onset of AD-Like Pathology in 3xTg-AD Mice
R. Velazquez et al.
MOLECULAR NEUROBIOLOGY (2019)
Impaired development of neocortical circuits contributes to the neurological alterations in DYRK1A haploinsufficiency syndrome
Juan Arranz et al.
NEUROBIOLOGY OF DISEASE (2019)
The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair
Steven E. Guard et al.
SCIENTIFIC REPORTS (2019)
DYRK1A inhibition suppresses STAT3/EGFR/Met signalling and sensitizes EGFR wild-type NSCLC cells to AZD9291
Yang-ling Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Upregulated Expression of MicroRNA-204-5p Leads to the Death of Dopaminergic Cells by Targeting DYRK1A-Mediated Apoptotic Signaling Cascade
Ching-Chi Chiu et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth
Jeroni Luna et al.
GUT (2019)
RCAN1 in the inverse association between Alzheimer's disease and cancer
Qiang Fu et al.
ONCOTARGET (2018)
Unexplored therapeutic opportunities in the human genome
Tudor I. Oprea et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
DYRK1A-haploinsufficiency in mice causes autistic-like features and febrile seizures
Matthieu Raveau et al.
NEUROBIOLOGY OF DISEASE (2018)
DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives
Fernanda Neumann et al.
SCIENTIFIC REPORTS (2018)
DYRK1A Protein, A Promising Therapeutic Target to Improve Cognitive Deficits in Down Syndrome
Anis Feki et al.
BRAIN SCIENCES (2018)
Frontotemporal dementia: latest evidence and clinical implications
Juan Joseph Young et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2018)
New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome
Leah J. Wilson et al.
CANCER RESEARCH (2018)
Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature
Thu Lan Nguyen et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes
Susana Garcia-Cerro et al.
NEUROBIOLOGY OF DISEASE (2017)
DYRK1A regulates Hap1-Dcaf7/WDR68 binding with implication for delayed growth in Down syndrome
Jianxing Xiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Inhibition of DYRK1A disrupts neural lineage specificationin human pluripotent stem cells
Stephanie F. Bellmaine et al.
ELIFE (2017)
Dyrk1 inhibition improves Alzheimer's disease-like pathology
Caterina Branca et al.
AGING CELL (2017)
Identification of a DYRK1A-mediated phosphorylation site within the nuclear localization sequence of the hedgehog transcription factor GLI1
Ben K. Ehe et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID
B. W. M. van Bon et al.
MOLECULAR PSYCHIATRY (2016)
Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling
Susanne Hille et al.
CARDIOVASCULAR RESEARCH (2016)
Inhibition of DYRK1A Stimulates Human β-Cell Proliferation
Ercument Dirice et al.
DIABETES (2016)
DYRK1A: A Promising Drug Target for Islet Transplant-Based Diabetes Therapies
Bengt-Frederik Belgardt et al.
DIABETES (2016)
DYRK1A inhibition as potential treatment for Alzheimer's disease
Silvia Stotani et al.
FUTURE MEDICINAL CHEMISTRY (2016)
An ID2-dependent mechanism for VHL inactivation in cancer
Sang Bae Lee et al.
NATURE (2016)
DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome
Arnaud Duchon et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2016)
The adaptor protein DCAF7 mediates the interaction of the adenovirus E1A oncoprotein with the protein kinases DYRK1A and HIPK2
Florian Glenewinkel et al.
SCIENTIFIC REPORTS (2016)
Structural mechanisms of DREAM complex assembly and regulation
Keelan Z. Guiley et al.
GENES & DEVELOPMENT (2015)
Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity
Eunju Im et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Chromatin-wide Profiling of DYRK1A Reveals a Role as a Gene-Specific RNA Polymerase II CTD Kinase
Chiara Di Vona et al.
MOLECULAR CELL (2015)
DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects in Down Syndrome
Sonia Najas et al.
EBIOMEDICINE (2015)
Phosphorylation and Inactivation of Glycogen Synthase Kinase 3β (GSK3β) by Dual-specificity Tyrosine Phosphorylation-regulated Kinase 1A (Dyrk1A)
Woo-Joo Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
DYRK1A Controls HIV-1 Replication at a Transcriptional Level in an NFAT Dependent Manner
Thijs Booiman et al.
PLOS ONE (2015)
The Down syndrome-related protein kinase DYRK1A phosphorylates p27Kip1 and Cyclin D1 and induces cell cycle exit and neuronal differentiation
Ulf Soppa et al.
CELL CYCLE (2014)
DYRK1A phoshorylates histone H3 to differentially regulate the binding of HP1 isoforms and antagonize HP1-mediated transcriptional repression
Suk Min Jang et al.
EMBO REPORTS (2014)
DYRK1A-mediated phosphorylation of GluN2A at Ser1048 regulates the surface expression and channel activity of GluN1/GluN2A receptors
Cristina Grau et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson's disease
M. J. Barallobre et al.
CELL DEATH & DISEASE (2014)
Triplication of DYRK1A causes retinal structural and functional alterations in Down syndrome
Ariadna Laguna et al.
HUMAN MOLECULAR GENETICS (2013)
Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth
Natividad Pozo et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer's?
Breland Smith et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Dual-specificity Tyrosine Phosphorylation-regulated Kinase 1A (Dyrk1A) Modulates Serine/Arginine-rich Protein 55 (SRp55)-promoted Tau Exon 10 Inclusion
Xiaomin Yin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome
Sebastien Malinge et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Regulation of alternative splicing of tau exon 10 by 9G8 and Dyrk1A
Shaohong Ding et al.
NEUROBIOLOGY OF AGING (2012)
DYRK1A: A master regulatory protein controlling brain growth
Faycal Guedj et al.
NEUROBIOLOGY OF DISEASE (2012)
DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles
Sergi Aranda et al.
FASEB JOURNAL (2011)
MNB/DYRK1A as a multiple regulator of neuronal development
Francisco J. Tejedor et al.
FEBS JOURNAL (2011)
Activation, regulation, and inhibition of DYRK1A
Walter Becker et al.
FEBS JOURNAL (2011)
The role of DYRK1A in neurodegenerative diseases
Jerzy Wegiel et al.
FEBS JOURNAL (2011)
DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly
Larisa Litovchick et al.
GENES & DEVELOPMENT (2011)
Splice Variants of the Dual Specificity Tyrosine Phosphorylation-regulated Kinase 4 (DYRK4) Differ in Their Subcellular Localization and Catalytic Activity
Chrisovalantis Papadopoulos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Regulation of RCAN1 Protein Activity by Dyrk1A Protein-mediated Phosphorylation
Min-Su Jung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A
Wei Qian et al.
NUCLEIC ACIDS RESEARCH (2011)
Hyperhomocysteinemia-induced Dyrk1a downregulation results in cardiomyocyte hypertrophy in rats
Lamia Raaf et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
DYRK1A and DYRK3 Promote Cell Survival through Phosphorylation and Activation of SIRT1
Xiumei Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Dyrk1A Phosphorylates p53 and Inhibits Proliferation of Embryonic Neuronal Cells
Joongkyu Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer's disease
Young Shin Ryu et al.
JOURNAL OF NEUROCHEMISTRY (2010)
MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling
Paula A. da Costa Martins et al.
NATURE CELL BIOLOGY (2010)
Dyrk1A Binds to Multiple Endocytic Proteins Required for Formation of Clathrin-Coated Vesicles
Noriko Murakami et al.
BIOCHEMISTRY (2009)
Attenuation of Notch signalling by the Down-syndrome-associated kinase DYRK1A
Javier Fernandez-Martinez et al.
JOURNAL OF CELL SCIENCE (2009)
Down Syndrome and Malignancies: A Unique Clinical Relationship A Paper from the 2008 William Beaumont Hospital Symposium on Molecular Pathology
Ana C. Xavier et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2009)
Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1
Kwan-Hyuck Baek et al.
NATURE (2009)
The Protein Kinase DYRK1A Regulates Caspase-9-Mediated Apoptosis during Retina Development
Ariadna Laguna et al.
DEVELOPMENTAL CELL (2008)
DYRK1A stabilizes HPV16E7 oncoprotein through phosphorylation of the threonine 5 and threonine 7 residues
Yuh-Jin Liang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome
Jianhua Shi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease
Soo-Ryoon Ryoo et al.
JOURNAL OF NEUROCHEMISTRY (2008)
THE DOWN SYNDROME CANDIDATE DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 1A PHOSPHORYLATES THE NEURODEGENERATION-RELATED SEPTIN 4
J. H. Sitz et al.
NEUROSCIENCE (2008)
Epidemiology of Diabetes and Diabetes-Related Complications
Anjali D. Deshpande et al.
PHYSICAL THERAPY (2008)
Nuclear trafficking of pro-apoptotic kinases in response to DNA damage
Kiyotsugu Yoshida
TRENDS IN MOLECULAR MEDICINE (2008)
Dual-specificity tyrosine phosphorylation-regulated kinase 1A does not require tyrosine phosphorylation for activity in vitro
Tatyana Adayev et al.
BIOCHEMISTRY (2007)
The expression of the testis-specific Dyrk4 kinase is highly restricted to step 8 spermatids but is not required for male fertility in mice
F. Sacher et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage
Naoe Taira et al.
MOLECULAR CELL (2007)
The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease
Ryo Kimura et al.
HUMAN MOLECULAR GENETICS (2007)
Dyrk1A phosphorylates α-synuclein and enhances intracellular inclusion formation
Eun Joo Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Phosphorylation of amphiphysin I by minibrain kinase/dual-specificity tyrosine phosphorylation-regulated kinase, a kinase implicated in Down syndrome
Noriko Murakami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21
Joseph R. Arron et al.
NATURE (2006)
The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma
XB Deng et al.
CANCER RESEARCH (2006)
Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models
I Ferrer et al.
NEUROBIOLOGY OF DISEASE (2005)
DYRK1A enhances the mitogen-activated protein kinase cascade in PC12 cells by forming a complex with Ras, B-Raf, and MEK1
PA Kelly et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Regulation of the proapoptotic activity of huntingtin interacting protein 1 by Dyrk1 and caspase-3 in hippocampal neuroprogenitor cells
JE Kang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs
PA Lochhead et al.
CELL (2005)
Dual-specificity tyrosine-phosphorylated and regulated kinase 1A (DYRK1A) interacts with the phytanoyl-CoA α-hydroxylase associated protein I (PAHX-AP1), a brain specific protein
M Bescond et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Dyrk1A potentiates steroid hormone-induced transcription via the chromatin remodeling factor Arip4
JH Sitz et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system
E Martí et al.
BRAIN RESEARCH (2003)
DYRK1 is a co-activator of FKHR (FOXO1a)-dependent glucose-6-phosphatase gene expression
F von Groote-Bidlingmaier et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice
V Fotaki et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Protein kinase Dyrk1 activates cAMP response element-binding protein during neuronal differentiation in hippocampal progenitor cells
EJ Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
